Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer

द्वारा Hong Xiang, Abigael G. Chan, Ago Ahene, David I. Bellovin, Rong Deng, Amy W. Hsu, Ursula Jeffry, Servando Palencia, Janine Powers, James Zanghi, Helen Collins
प्रकाशित 2021-01-01